“BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer” (2022) Majalah Kedokteran Bandung, 54(4), pp. 221–227. doi:10.15395/mkb.v54n4.2797.